Potassium: Benefits, Forms, Dosing, and Safety Guide

Potassium: Benefits, Forms, Dosing, and Safety Guide

Last Updated:

Table of Contents

Key safety points

  • ACE inhibitors, angiotensin receptor blockers (ARBs) and potassium-sparing diuretics (spironolactone, amiloride) reduce potassium excretion and can cause hyperkalemia. If you take one, talk to your doctor before using potassium supplements or salt substitutes [14, 81].
  • People with chronic kidney disease can develop hyperkalemia even at normal intakes. Do not use potassium supplements or potassium-enriched salt substitutes without your doctor's agreement [14, 40, 79].
  • Hyperkalemia is also more likely with diabetes, heart failure, adrenal insufficiency or liver disease [14, 83].
  • No upper limit is set for healthy people, but very large amounts from supplements or salt substitutes could still cause acute hyperkalemia [14].
  • Severe hyperkalemia can cause muscle weakness, paralysis and dangerous heart rhythms. For a new irregular or racing heartbeat, paralysis, chest pain, fainting or severe weakness, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK) or go to the emergency department [14].
  • Potassium salts in some tablet medicines have been linked with small-bowel injury, which is why most supplements stay at 99 mg or less [14]. Stop and get medical help for belly pain, vomiting or bleeding [26].
  • Supplements can cause minor stomach and bowel upset [14].

1. Overview

Potassium is an essential nutrient and the most abundant intracellular cation in the body. It is required for normal cell function because of its role in maintaining intracellular fluid volume and transmembrane electrochemical gradients [1, 2]. The total amount of potassium in the adult body is approximately 45 millimole (mmol) per kilogram of body weight — roughly 140 g for a 175-pound adult [1]. Most potassium resides inside cells, with only a small amount in extracellular fluid. The intracellular concentration of potassium is about 30 times higher than the extracellular concentration, and this gradient is maintained via the sodium-potassium (Na+/K+) ATPase transporter [1, 2].

This transmembrane electrochemical gradient is essential for proper nerve transmission, muscle contraction and kidney function [1, 2, 14]. Potassium also has a strong relationship with sodium — the main regulator of extracellular fluid volume — and plays a critical role in blood pressure regulation by promoting vasodilation and increasing urinary sodium excretion [1, 4].

Normal serum concentrations of potassium range from approximately 3.6 to 5.0 mmol/L [1, 14]. Potassium is absorbed via passive diffusion primarily in the small intestine, with approximately 90% of ingested potassium being absorbed [1, 5]. The kidneys are the primary regulators of potassium balance, controlling excretion in response to changes in dietary intake. A minimum of approximately 5 mmol (about 195 mg) of potassium is excreted daily in urine, and combined with other obligatory losses, potassium balance cannot be achieved with intakes less than about 400-800 mg/day [1].

Deficiency Is Increasing

Potassium deficiency is a growing concern. An analysis of NHANES data on 28,379 men and 29,617 women aged 12 to 80, collected from 1999 to 2016, showed average serum potassium falling from 4.14 to 3.97 mmol/L over that period, while the share of people with hypokalemia rose from 3.78% to 11.06%. Non-Hispanic black people had a higher prevalence than non-Hispanic white people [6]. The authors suggested that falling potassium levels in crops and rising consumption of processed food are possible explanations that need further study [6].

Dietary surveys consistently show that Americans consume less potassium than recommended. According to NHANES 2013-2014 data, the average daily potassium intake from foods is 3,016 mg for men and 2,320 mg for women aged 20 and over, well below the Adequate Intakes of 3,400 mg for men and 2,600 mg for women [1, 7]. Potassium is identified as a "nutrient of public health concern" by the Dietary Guidelines for Americans [7]. Average potassium intakes also vary by race, with non-Hispanic blacks consuming less (2,449 mg/day) than non-Hispanic whites (2,697 mg/day) [1].

Symptoms of Deficiency

Severe potassium deficiency causes hypokalemia (serum potassium level below 3.6 mmol/L), which affects up to 21% of hospitalized patients, most often due to diuretic use [1, 8]. Symptoms progress with severity:

  • Mild: Constipation, fatigue, muscle weakness, malaise, listlessness, mood changes
  • Moderate: Numbness, tingling, muscle cramps, nausea, vomiting, irrational behavior
  • Severe (serum potassium below ~2.5 mmol/L): Polyuria (large volume of dilute urine), muscular paralysis, poor respiration, cardiac arrhythmias, encephalopathy in patients with kidney disease. Severe hypokalemia can be life threatening due to its effects on cardiac function [1, 14].

Causes of Deficiency

Hypokalemia is rarely caused by low dietary potassium intake alone. Common causes include [1, 14]:

  • Diuretic medications: Both loop diuretics (furosemide, bumetanide) and thiazide diuretics (chlorothiazide, metolazone) increase urinary potassium excretion
  • Gastrointestinal losses: Diarrhea, vomiting or laxative misuse. Vomiting produces metabolic alkalosis, leading to potassium losses in the kidneys [14]
  • Inflammatory bowel disease: Potassium secretion increases in the colon, compounded by chronic diarrhea [1]
  • Proton-pump inhibitors: FDA adverse event reports link lansoprazole, omeprazole, pantoprazole and esomeprazole with hypokalemia [93]
  • Other medicines: Some asthma relievers (beta2 agonists such as albuterol), corticosteroids, theophylline and caffeine, and insulin overdose can also lower potassium [9]
  • GLP-1 receptor agonists: A case report described two women, aged 48 and 45, admitted to hospital with hypokalemia while taking semaglutide (Ozempic, Wegovy). One had nausea and vomiting; the other was also taking the diuretic chlorthalidone. The authors said the cause may be multifactorial [10]
  • Refeeding syndrome: The metabolic response to initial refeeding after a starvation period, due to potassium's movement into cells [1]
  • Pica: Consuming clay binds potassium in the gastrointestinal tract, increasing excretion [1]
  • Heavy sweating and dialysis [1]

Magnesium and Potassium: A Critical Connection

Low potassium and low magnesium often occur together. The NIH notes that more than 50% of people with clinically significant hypokalemia might have magnesium deficiency [14]. One review found magnesium deficiency in 38% to 42% of potassium-depleted patients [12]. Uncorrected magnesium deficiency may make low potassium hard to correct with potassium alone [11, 12]. One proposed mechanism is that low magnesium inside cells releases a brake on ROMK potassium channels in the kidney, so more potassium is lost in the urine [11]. Whang and colleagues suggested that this problem may arise in heart failure, digitalis toxicity and cisplatin treatment, and with potent loop diuretics [12]. In people with both hypomagnesemia and hypokalemia, both should be treated at the same time [12, 14].

2. Forms and Bioavailability

Supplements most often use potassium chloride, but citrate, phosphate, aspartate, bicarbonate and gluconate forms are also sold [14]. About 90% of ingested potassium is absorbed [5, 14]. Only a few studies have compared how well the different supplement forms are absorbed [14].

A 2016 dose-response trial found that humans absorb about 94% of potassium gluconate from supplements, and this absorption rate is similar to that of potassium from potatoes [15]. Liquid forms of potassium chloride are absorbed within a few hours. Enteric-coated tablet forms of potassium chloride are absorbed less rapidly than liquid forms [14, 16].

Comparison Table

Form Elemental K (% of compound) Key Properties Common Uses
Potassium Chloride (KCl) 52% Highest elemental potassium per gram. The most common form in supplements and the form used in salt substitutes [14]. Salt substitutes, prescription hypokalemia treatment, clinical trials on blood pressure
Potassium Citrate 38.3% Well-absorbed. Citrate component provides additional benefit for kidney stones by raising urine pH and forming complexes with calcium [17, 18]. Kidney stone prevention, blood pressure support, general supplementation
Potassium Gluconate 16.7% Low elemental potassium content, so more of the compound is needed for the same dose. Absorbed about as well as potassium from potatoes [15]. General supplementation
Potassium Bicarbonate ~39% Alkalizing effect. May support bone health via acid-base balance [25]. One case report used it with potassium citrate to treat uric acid stones [19]. Bone health support, kidney stone management
Potassium Phosphate ~28% Phosphate component may reduce urinary calcium in hypercalciuria patients [21]. Kidney stone disease with hypercalciuria
Potassium Aspartate ~25% Sometimes combined with magnesium aspartate. Limited data as standalone form. Combined mineral supplements
Potassium Acetate ~40% Well-absorbed. Less commonly available in over-the-counter supplements. Specialty formulations

Key Principles for Form Selection

For general supplementation: Most people do not need a potassium supplement if they eat potassium-rich foods. If you use one, check the Supplement Facts panel, which lists the elemental potassium rather than the weight of the whole compound [14].

For kidney stone prevention: Potassium citrate is the form studied, and the citrate rather than the potassium is thought to do the work: it binds urinary calcium and raises urine pH, which hinders calcium oxalate crystals [14, 17].

For blood pressure management: Most clinical trials have used potassium chloride, though potassium-enriched salt substitutes (containing 25-75% potassium chloride) offer a practical way to increase potassium and reduce sodium simultaneously [22, 23].

For bone health: Potassium citrate and potassium bicarbonate are preferred over potassium chloride because the alkaline potassium salts help counter metabolic acidosis that may contribute to bone loss. Potassium chloride does not have this alkalizing effect [24, 25].

Important Label Reading Note

Product names can mislead. The Supplement Facts panel declares the elemental potassium, not the weight of the whole compound [14], and potassium gluconate is only about 16.7% potassium by weight. Doses are sometimes given in milliequivalents (mEq); 1 mEq is 39.1 mg of potassium [14].

The 99 mg Supplement Limit

Most potassium-only supplements provide no more than 99 mg potassium per serving [14]. This is because the FDA has ruled that some oral drug products containing potassium chloride and providing more than 99 mg potassium are not safe due to associations with small-bowel lesions [26, 27]. The FDA requires certain potassium salts containing more than 99 mg per tablet to carry a warning about this risk [26]. While Congress has ruled that the FDA cannot limit the amount of a nutrient in a dietary supplement except for safety reasons, most manufacturers voluntarily limit potassium to 99 mg per capsule or tablet [14].

The FDA warning rule is aimed at capsules and coated tablets swallowed without dilution [26]. The rule asks that other tablets be dissolved, and liquids diluted, before they are swallowed, to protect the gut from concentrated potassium [26].

Also on microvitamin.com

Potassium Fiber Drink is a lemon-lime powder with 500 mg of potassium, as potassium citrate, and 8 g of fiber in each scoop: more potassium than the 99 mg typical of the potassium pills this section describes. Contains 500 mg of added potassium per serving (1,000 mg at the two-scoop daily maximum). Talk to your doctor before using this product if you have kidney disease, if you have been told to limit potassium, or if you take an angiotensin converting enzyme inhibitor (often called an ACE inhibitor), an angiotensin receptor blocker, a potassium-sparing diuretic, or any other potassium supplement. Not for children. Keep out of reach of children. If you are pregnant or breastfeeding, ask your doctor first. See Potassium Fiber Drink

3. Evidence for Health Benefits

Blood Pressure

More potassium from food or supplements may help lower blood pressure, and low intakes raise the risk most when sodium intake is high [14, 22]. African Americans tend to have lower potassium intakes [14], and one small study found that they cleared an intravenous potassium load more slowly than white Americans [28].

Meta-analyses of potassium supplementation:

A 2017 meta-analysis of 25 randomized controlled trials in 1,163 participants with hypertension found significant reductions in systolic blood pressure (SBP) by 4.48 mmHg and diastolic blood pressure (DBP) by 2.96 mmHg with potassium supplementation, mostly as potassium chloride at 1,173-4,692 mg/day for 4-15 weeks [30]. Another meta-analysis of 15 RCTs found that potassium supplements (mostly potassium chloride at 2,346-2,541 mg/day) for 4-24 weeks in 917 patients significantly reduced both SBP and DBP. The effect was greatest in patients with hypertension, reducing SBP by 6.8 mmHg and DBP by 4.6 mmHg [31]. Two earlier meta-analyses of 19 trials [32] and 33 trials [33] had similar findings.

A similar analysis by the NASEM committee including 16 trials found that potassium supplements significantly lowered SBP by 6.87 mmHg and DBP by 3.57 mmHg. However, these effects were stronger among studies that included participants with hypertension; for studies including only normotensive participants, the effects were not statistically significant [34].

Nuances and ceiling effects:

US guidelines advise adults with high blood pressure to get more potassium, preferably from food [35, 39]. A 2020 dose-response meta-analysis of 32 trials found that the blood pressure benefit weakened above a 30 mmol/day difference in potassium excretion between the supplement and control groups, blood pressure rose above a difference of about 80 mmol/day, and that rise appeared in people treated for high blood pressure but not in untreated people [36].

An older Cochrane review pooled five trials in 425 adults with raised blood pressure and found large but statistically non-significant falls in systolic and diastolic pressure with potassium supplements [37].

The role of sodium reduction:

The AHRQ systematic review found that reducing sodium intake decreased blood pressure, but adding potassium via food or supplements on top of sodium reduction did not reduce blood pressure further. This suggests that at least some of the beneficial effects attributed to potassium may be driven by the accompanying reduction in sodium intake [34]. Based on 13 RCTs, potassium-containing salt substitutes significantly reduced SBP by 5.58 mmHg and DBP by 2.88 mmHg [34]. A later analysis of the salt substitute trial (SSaSS), which Brad covered, estimated that 61% to 88% of its blood pressure fall came from the added potassium rather than the lower sodium [92].

Expert consensus:

Guidelines favour more potassium from food over high-dose supplements, with care for people with chronic kidney disease or on medicines that raise potassium [35, 39]. Potassium-enriched salt substitutes are covered below [40].

Stroke and Cardiovascular Disease

Higher potassium intakes have been associated with a decreased risk of stroke and possibly other cardiovascular diseases [4, 41].

Stroke risk reduction:

A meta-analysis of 11 prospective cohort studies in 247,510 adults found that a 1,640 mg/day higher potassium intake was associated with a significant 21% lower risk of stroke, as well as nonsignificant lower risks of coronary heart disease and total cardiovascular disease [42]. Similarly, a meta-analysis of 9 cohort studies found a 24% lower stroke risk with higher potassium intakes [43].

A 2016 meta-analysis of 16 cohort studies with 639,440 participants found that those with the highest potassium intakes (median 4,027 mg/day) had a 15% lower risk of stroke than those with the lowest intakes (median 2,053 mg/day). Participants consuming approximately 3,500 mg/day had the lowest stroke risk. Importantly, even when blood pressure was accounted for, higher potassium intakes still produced a significant 13% lower risk of stroke — suggesting that mechanisms beyond blood pressure reduction, such as improved endothelial function and reduced free radical formation, may be involved [44].

FDA-approved health claim: The FDA has approved the following claim: "Diets containing foods that are a good source of potassium and that are low in sodium may reduce the risk of high blood pressure and stroke" [45].

Salt Substitutes and Cardiovascular Outcomes

Replacing regular salt with a potassium-enriched substitute lowers blood pressure modestly. A review of these products reported average falls of 5.58 mmHg systolic and 2.88 mmHg diastolic, and flagged a possible higher risk of hyperkalemia in people whose kidneys clear potassium poorly, for example in chronic kidney disease [46].

The landmark SSaSS trial (Salt Substitute and Stroke Study):

The trial enrolled 20,995 people in 600 villages in rural China who had a history of stroke or were 60 years or older with high blood pressure. Over a mean follow-up of 4.74 years, villages using a salt substitute of 75% sodium chloride and 25% potassium chloride had lower rates of stroke (rate ratio 0.86, 95% CI 0.77 to 0.96), major cardiovascular events (rate ratio 0.87, 95% CI 0.80 to 0.94) and death (rate ratio 0.88, 95% CI 0.82 to 0.95) than villages using regular salt. Serious adverse events attributed to hyperkalemia were not significantly more common (rate ratio 1.04, 95% CI 0.80 to 1.37) [23]. In a later analysis of participants with a past stroke, the substitute lowered recurrent stroke (rate ratio 0.86, 95% CI 0.77 to 0.95), with a 30% relative reduction in hemorrhagic stroke and a 21% relative reduction in stroke-related deaths; the mean systolic blood pressure difference was 2.05 mm Hg [47].

Elderly care facility study:

A separate cluster-randomized trial in 48 elderly care facilities in China (1,612 residents aged 55 or older) found that a salt substitute (62.5% sodium chloride, 25% potassium chloride) used for 2 years lowered systolic blood pressure by 7.1 mmHg and led to fewer cardiovascular events (hazard ratio 0.60, 95% CI 0.38 to 0.96) than usual salt, with no effect on total mortality (hazard ratio 0.84, 95% CI 0.63 to 1.13) [48]. The salt substitute raised blood potassium and led to more frequent biochemical hyperkalemia, but this was not associated with adverse clinical outcomes [48].

Expert recommendations: A review of 32 hypertension and 14 kidney guidelines found their advice on potassium-enriched salt incomplete and inconsistent. Its authors proposed draft wording: a salt of 75% sodium chloride and 25% potassium chloride for all patients with hypertension, unless they have advanced kidney disease, take a potassium supplement or a potassium-sparing diuretic, or have another contraindication [40].

Kidney Stone Prevention

Some potassium salts, mainly potassium citrate, may lower the risk of kidney stones. The mechanism primarily involves citrate rather than potassium itself — citrate forms complexes with urinary calcium and increases urine pH, inhibiting calcium oxalate crystal formation [17, 49].

Clinical trial evidence:

In a randomized trial of people left stone free by shockwave lithotripsy, none of those given potassium citrate 60 mEq a day had a new stone at 12 months, against a 28.5% recurrence rate in untreated controls [18].

In a clinical trial of 57 patients with at least two kidney stones over the prior 2 years and hypocitraturia (low urinary citrate), supplementation with 1,173-2,346 mg potassium (as potassium citrate) for 3 years significantly reduced kidney stone formation compared with placebo [51]. This was included in a 2015 Cochrane Review of 7 studies (477 participants) that found potassium citrate salts significantly reduced the risk of new stones and decreased stone size [17].

In a double-blind trial in 64 people with recurrent calcium oxalate stones, potassium-magnesium citrate (42 mEq potassium, 21 mEq magnesium and 63 mEq citrate a day) for up to 3 years lowered the share forming new stones from 63.6% on placebo to 12.9% (relative risk of treatment failure 0.16, 95% CI 0.05 to 0.46); the authors put the reduction in recurrence risk at 85% [52].

Potassium phosphate has also been tested: in a 4-year open trial in 25 people with absorptive hypercalciuria, a major cause of kidney stones, slow-release potassium phosphate (8 mEq of potassium per tablet, 4 tablets twice daily) lowered urinary calcium from 264 to 181 mg a day [21].

Uric acid stones:

A case report described bilateral uric acid kidney stones that were successfully treated by alkalizing the urine with potassium citrate and potassium bicarbonate [19]. In a series of people with uric acid stones, long-term potassium citrate (usually 60 mEq a day) raised urine pH, and new stone formation fell from 1.20 to 0.01 stones a year [20].

Observational data:

In a cohort of 45,619 men aged 40-75 with no history of kidney stones, those with the highest potassium intakes (at least 4,042 mg/day) had a 51% lower risk of kidney stones over 4 years than those with the lowest intakes (2,895 mg/day or less) [53]. Similarly, among more than 90,000 women aged 34-59 in the Nurses' Health Study, those consuming more than 4,099 mg potassium per day had a 35% lower risk of kidney stones over 12 years compared to those averaging less than 2,407 mg/day [54].

Important note: Most potassium-only supplements contain no more than 99 mg of potassium, far below the 1,173 to 2,346 mg of potassium a day used in the kidney stone trials [14]. Doses that high are a medical treatment and should be taken only under a doctor's care [26].

Bone Health

Observational studies suggest that increased potassium intake from fruits and vegetables is associated with increased bone mineral density [55]. The underlying mechanism may involve potassium's effect on acid-base balance — diets high in acid-forming foods (meats, cereal grains) contribute to metabolic acidosis that may adversely affect bone, while alkaline potassium salts (citrate, bicarbonate — but not chloride) may help preserve bone tissue [56].

Observational evidence:

In the Framingham Heart Study, higher potassium intake was associated with significantly greater bone mineral density in 628 elderly men and women [24]. The DASH diet, which provides three times more potassium than the average American diet, significantly reduced biochemical markers of bone turnover [58]. However, DASH also increases magnesium and calcium intakes, so potassium's independent contribution cannot be determined.

Clinical trial evidence:

A trial of 52 healthy men and women older than 55 found that potassium citrate supplementation at 2,346 mg or 3,519 mg potassium for 6 months significantly reduced urinary calcium excretion compared to placebo [59].

In a trial of 201 healthy adults 65 or older, potassium citrate (2,346 mg potassium a day) for 2 years significantly increased bone mineral density at the lumbar spine and improved bone microarchitecture compared with placebo; everyone also took calcium (500 mg/day) and vitamin D3 (400 IU/day) [14, 60].

Supplemental potassium bicarbonate (mean doses of 2,893 or 4,340 mg/day potassium) for 84 days significantly reduced biochemical markers of bone turnover and urinary calcium excretion in healthy older adults [25].

Negative finding: A trial in 276 postmenopausal women aged 55-65 found that potassium citrate at 723 mg or 2,170 mg potassium for 2 years did NOT significantly reduce bone turnover or increase bone mineral density at the hip or lumbar spine compared to placebo [62].

Synthesis: Higher potassium intakes from diets emphasizing fruits and vegetables likely improve bone health, but the evidence from supplementation trials is mixed. More research is needed to separate potassium's own effect on bone from the rest of the diet.

Blood Glucose Control and Type 2 Diabetes

Potassium is needed for insulin secretion from pancreatic cells, and hypokalemia can impair insulin secretion and lead to glucose intolerance [1, 2, 63].

Observational evidence:

Numerous studies have found associations between lower potassium intakes, lower serum or urinary potassium levels, and increased rates of fasting glucose, insulin resistance, and type 2 diabetes [63, 64, 65, 66, 67]. These associations may be stronger in African Americans [64, 66].

In one study of 1,066 adults aged 18-30 without diabetes, those with urinary potassium levels in the lowest quintile were more than twice as likely to develop type 2 diabetes over 15 years compared to those in the highest quintile [64]. Among the 4,754 participants with dietary intake data, African Americans with lower potassium intakes had significantly greater diabetes risk over 20 years, but this association was not found in whites.

An analysis of 84,360 women aged 34-59 in the Nurses' Health Study found that those in the highest quintile of potassium intake had a 38% lower risk of developing type 2 diabetes over 6 years compared to those in the lowest quintile [65].

Serum potassium levels were inversely associated with fasting glucose levels in 5,415 participants aged 45-84 from the Multi-Ethnic Study of Atherosclerosis, but these levels had no significant association with diabetes risk over 8 years of follow-up [67].

Clinical trial evidence:

In a small trial of 29 African American adults with prediabetes and low to normal serum potassium levels (3.3-4.0 mmol/L), supplementation with 1,564 mg potassium (as potassium chloride) for 3 months significantly lowered fasting glucose levels, but did not improve glucose or insulin measures during an oral glucose tolerance test [68].

Synthesis: Observational data are promising, but clinical trial evidence is very limited. More RCTs are needed before potassium's role in blood glucose control and type 2 diabetes prevention can be confirmed.

Rheumatoid Arthritis

An earlier food survey found low dietary potassium in people with rheumatoid arthritis (RA) [70]. In a 16-week randomized trial in 172 people with RA on standard care, 155 of whom completed it, a potassium-rich vegetarian diet plus a potassium food supplement gave a mean change in pain score of -2.23 (95% CI -2.99 to -1.48), the best result of the three arms, and a high daily potassium intake of 5 to 7.5 g was linked with low pain. Pain also fell in the routine-diet control arm (-1.25, 95% CI -2.03 to -0.46), and swollen and tender joint counts, ESR, CRP, Disease Activity Score 28 and painkiller use did not differ between the arms. The trial had no placebo, and the authors call for further studies [70].

Muscle Cramps and Restless Legs

Night-time leg cramps are probably caused by muscle fatigue and nerve dysfunction rather than by electrolyte problems such as low potassium [71].

One small uncontrolled study tested potassium citrate in moderate to severe restless legs syndrome [72]. Without a control group, it cannot show whether potassium helped.

COVID-19 and Hypokalemia

Hypokalemia is common in people admitted to hospital with COVID-19. In a study of 175 patients in Wenzhou, China, 18% had severe hypokalemia (plasma potassium below 3 mmol/L) and 37% had milder hypokalemia. Those with severe hypokalemia were given 40 mEq of potassium a day and responded well as they recovered [73].

In 290 patients admitted outside intensive care in Modena, Italy, 41% developed hypokalemia, mostly mild, and it was not linked with transfer to intensive care or death [74].

The Wenzhou authors suggested that the virus binds and degrades ACE2, an enzyme of the renin-angiotensin system, which leads to continuing potassium loss through the kidneys [73].

Adequate Intakes (AIs)

The National Academies of Sciences, Engineering, and Medicine updated the AIs for potassium in 2019 [34]. Note: these replaced older (2005) recommendations that set the AI for all adults at 4,700 mg. The committee found too little data to set an average requirement, so it based the AIs on the highest median potassium intakes in healthy children and adults [14, 75].

Age Group Male (mg/day) Female (mg/day)
1-3 years 2,000 2,000
4-8 years 2,300 2,300
9-13 years 2,500 2,300
14-18 years 3,000 2,300
19-50+ years 3,400 2,600
Pregnancy -- 2,900 (2,600 if under 19)
Lactation -- 2,800 (2,500 if under 19)

No Upper Limit Established

No Tolerable Upper Intake Level (UL) has been set for potassium: in healthy people with normal kidney function, the kidneys excrete the excess, and the NASEM committee found no evidence that high intakes cause hyperkalemia in such adults [1, 14]. In people with chronic kidney disease, or who take medicines such as ACE inhibitors or potassium-sparing diuretics, even intakes below the AI can cause hyperkalemia. They should ask a doctor or registered dietitian how much potassium to have from all sources [14].

Supplementation Dosing by Indication

Preventing potassium loss: For people taking loop or thiazide diuretics, experts recommend monitoring potassium and starting a supplement if needed [14]. Take potassium supplements only on your doctor's advice, especially if you have kidney disease or take blood-pressure medicines.

Treating potassium deficiency: Your doctor sets the dose. If magnesium is also low, both should be treated at the same time [14].

Blood pressure support (from food): 3,500-5,000 mg/day total from dietary sources. Guidelines favour food over high-dose supplements [35, 39]. In trials, blood pressure rose in people treated for high blood pressure when supplements raised potassium excretion by more than about 80 mmol a day over control [36].

Kidney stone prevention (potassium citrate): Doses used in clinical trials range from 1,173-2,346 mg/day of potassium (30 to 60 mEq), typically as divided doses of potassium citrate. These are well above standard supplement amounts and require medical supervision [17, 18, 51].

Bone health: 2,346-4,340 mg/day (as potassium citrate or bicarbonate) in clinical trials [25, 59, 60]. These doses are far above standard supplement levels.

Practical Considerations

Most potassium-only supplements provide no more than 99 mg potassium per serving [14], so trial doses would take many pills. Doses that high are a medical treatment, and the FDA warning on small-bowel injury is aimed at capsules and coated tablets rather than forms dissolved before drinking [26].

The most practical approach for most people is to increase potassium through dietary changes (fruits, vegetables, legumes, potatoes) and the use of potassium-enriched salt substitutes.

Using potassium-containing dietary supplements does not significantly increase total potassium intakes in the U.S. population — supplement use adds a mean of only 87 mg to daily intakes [1].

5. Safety and Side Effects

Common Side Effects

Potassium supplements can cause minor stomach and bowel side effects [14, 34]. Watch for:

  • Signs of high potassium: muscle weakness, or a burning or prickling feeling in the hands or feet [14]. Stop the supplement and get medical help the same day. For a new irregular or racing heartbeat, paralysis, chest pain, fainting or severe weakness, call your local emergency number (111 in NZ, 000 in Australia, 911 in the US, 999 in the UK) or go to the emergency department [14].
  • Pain on swallowing, which can mean a tablet has stuck. Take tablets standing, with at least 100 ml of water [76].

Esophageal and Intestinal Risks

Tablets often stick in the oesophagus: in a study of 121 healthy volunteers, 22% of swallows took more than 90 seconds [76]. A potassium chloride tablet that lodges there may irritate the lining [94]. Potassium salts in some medicines, such as enteric-coated potassium chloride tablets, have been linked with small-bowel lesions that cause obstruction, bleeding and perforation [14, 27]. The FDA rule links this injury to concentrated potassium salts in the gut, though a cause has not been proven [26]. Stop and get medical help for belly pain, vomiting or bleeding [26]. For this reason, the FDA requires some oral drugs with more than 99 mg of potassium to carry a warning [14, 26]. The warning is aimed at capsules and coated tablets, not liquid, effervescent or powder forms taken dissolved [26].

Hyperkalemia

In healthy individuals with normal kidney function, high dietary potassium intakes do not pose a health risk because the kidneys efficiently eliminate excess amounts [1, 34]. However, hyperkalemia (serum potassium above 5.0 mmol/L) can occur in people with impaired kidney function or those taking certain medications [1, 34].

Very high amounts of potassium from supplements or salt substitutes could potentially exceed the kidney's capacity to excrete potassium, causing acute hyperkalemia even in healthy individuals. Chronic ingestion of supplement doses up to 15,600 mg for 5 days in healthy people can increase plasma potassium, but not beyond the normal range [1].

Symptoms of hyperkalemia progress with severity:

  • Mild: Often asymptomatic
  • Moderate: Muscle weakness, paresthesias (burning or prickling sensation in extremities)
  • Severe: Paralysis, heart palpitations, cardiac arrhythmias that could be life-threatening [1]

Kidney Disease

In chronic kidney disease, impaired potassium excretion means even dietary intakes below the AI can cause hyperkalemia, so people with kidney disease should agree their potassium intake from all sources, including supplements, with a doctor or registered dietitian [14]. Too little potassium may also be a problem. In 415 people on hemodialysis, those in the lowest third of dietary potassium intake had higher mortality than those in the highest third (adjusted hazard ratio 1.74, 95% CI 1.14 to 2.66). The authors suggest that overly strict potassium restriction may be harmful in hemodialysis [77].

Premenstrual Syndrome (PMS)

Higher potassium intake may be associated with a higher risk of PMS, though the result was borderline. In a case-control study nested in the Nurses' Health Study II, women in the highest fifth of potassium intake had a relative risk of PMS of 1.46 (95% CI 0.99 to 2.15) compared with the lowest fifth [78].

Salt Substitute Risks

People with kidney disease should use potassium-enriched salt substitutes only with their doctor's agreement, because these products may push potassium dangerously high [14, 79]. In one report, a man aged 88 with chronic kidney disease, in hospital for a bone infection, developed marked but symptom-free hyperkalemia (7.5 mEq/L) after his family brought in a potassium-enriched salt substitute to flavour his meals [79]. A 2024 review proposed excluding people with advanced kidney disease, or taking a potassium supplement or potassium-sparing diuretic [40]. Hyperkalemia is also more likely in people with diabetes, heart failure, adrenal insufficiency or liver disease, and in those taking ACE inhibitors or ARBs [14, 81, 83].

High Potassium from Food: A Case Report

A case report described a 79-year-old woman who ate a mango every night before sleep and had muscle cramps during sleep; the author suggested potassium overload from the mangos as a possible cause [80].

6. Drug Interactions

Several classes of medications interact with potassium in potentially dangerous ways. People taking these medications should discuss potassium intake with their healthcare providers.

Drugs That Increase Potassium Levels (Risk of Hyperkalemia)

Drug Class Examples Mechanism Clinical Concern
ACE inhibitors Benazepril (Lotensin), captopril, enalapril, lisinopril Reduce urinary potassium excretion Published estimates vary; up to 10% of people on an ACE inhibitor or ARB may develop at least mild hyperkalemia, and the risk is higher with kidney disease. Check potassium soon after starting [81]. Life-threatening hyperkalemia is rare but possible [83].
Angiotensin receptor blockers (ARBs) Losartan (Cozaar), irbesartan, olmesartan, valsartan Reduce urinary potassium excretion Published estimates vary; up to 10% may develop at least mild hyperkalemia, as with ACE inhibitors, and the risk is higher with kidney disease [81]. Life-threatening hyperkalemia is rare but possible: a woman aged 58 whose only risk factor was an ARB developed sudden chest pressure, light-headedness and a potassium level of 9.1 mmol/L [83].
Potassium-sparing diuretics Amiloride (Midamor), spironolactone (Aldactone), triamterene Reduce renal potassium excretion Can cause hyperkalemia. Monitor potassium levels closely, especially with impaired kidney function [1, 84].
Trimethoprim/sulfamethoxazole Bactrim, Septra Impairs potassium excretion In people aged 66 or older on an ACE inhibitor or ARB, it was linked with more hospital admissions for hyperkalemia within 14 days than amoxicillin (adjusted odds ratio 6.7, 95% CI 4.5 to 10.0) [95]. Do not add potassium supplements or salt substitutes without your doctor's agreement.

Drugs That Decrease Potassium Levels (Risk of Hypokalemia)

Drug Class Examples Mechanism Clinical Concern
Loop diuretics Furosemide (Lasix), bumetanide (Bumex) Increase urinary potassium excretion Can cause hypokalemia. Supplementation may be necessary [1, 84].
Thiazide diuretics Chlorothiazide (Diuril), hydrochlorothiazide, metolazone (Zaroxolyn) Increase urinary potassium excretion Can cause hypokalemia. Monitor potassium status [1, 84].
Beta2 agonists Albuterol (salbutamol), epinephrine, ephedrine Transcellular shift Can lower serum potassium [9].
Corticosteroids Hydrocortisone, fludrocortisone, prednisone Renal potassium loss Can lower potassium [9].
Proton-pump inhibitors Omeprazole, esomeprazole, pantoprazole, lansoprazole Unclear mechanism Linked with hypokalemia in FDA adverse event reports [93].
Laxatives Various Increase fecal potassium loss Repeated use or abuse increases hypokalemia risk [1].
Xanthines Theophylline, caffeine Shift of potassium into cells Can lower serum potassium [9].
GLP-1 receptor agonists Semaglutide (Ozempic, Wegovy) Unclear; may be multifactorial Case reports of hypokalemia needing hospital care [10].

ACE Inhibitors, ARBs, and COVID-19

Early in the pandemic, some authors suggested that ACE inhibitors and ARBs might raise ACE2 levels and so increase the risk of severe COVID-19 [85, 86]. Others found no human data to support this and advised that people keep taking these medicines [87].

7. Dietary Sources

Foods are the best source of potassium for most people, as they provide forms of potassium (phosphate, sulfate, citrate) that are naturally well absorbed [1, 4]. The body absorbs approximately 85-90% of dietary potassium [1].

Top Food Sources

Food Serving Potassium (mg)
Apricots, dried 1/2 cup 755
Lentils, cooked 1 cup 731
Acorn squash, mashed 1 cup 644
Prunes, dried 1/2 cup 635
Raisins 1/2 cup 618
Potato, baked (flesh only) 1 medium 610
Orange juice 1 cup 496
Soybeans, boiled 1/2 cup 443
Banana 1 medium 422
Milk, 1% 1 cup 366
Spinach, raw 2 cups 334
Chicken breast, grilled 3 oz 332
Yogurt, fruit variety, nonfat 6 oz 330
Salmon, Atlantic, farmed 3 oz 326
Beef, top sirloin, grilled 3 oz 315
Tomato, raw 1 medium 292

Source: NIH ODS fact sheet [14], drawing on USDA FoodData Central [89].

Additional Potassium-Rich Foods

Meats, poultry, fish, milk, yogurt and nuts also contain potassium, as do soymilk, broccoli and cantaloupe [14].

Practical Notes on Dietary Potassium

  • Refining grains reduces potassium: Whole-wheat flour and brown rice are much higher in potassium than white wheat flour and white rice [1].
  • Top dietary sources in the U.S.: Milk, coffee, tea, other nonalcoholic beverages, and potatoes are the top potassium sources for American adults. For children: milk, fruit juice, potatoes, and fruit [90, 91].
  • Food first for blood pressure: The best way to raise potassium intake is to eat more fruit and vegetables [4].
  • Salt substitutes as a dietary strategy: Potassium-enriched salt substitutes, such as a blend of 75% sodium chloride and 25% potassium chloride, cut sodium and add potassium in one step [40, 46].

8. References

[1] National Academies of Sciences, Engineering, and Medicine. "Dietary Reference Intakes for Sodium and Potassium." Washington, DC: The National Academies Press; 2019. https://doi.org/10.17226/25353

[2] Stone MS, Martyn L, Weaver CM. "Potassium intake, bioavailability, hypertension, and glucose control." Nutrients. 2016;8(7):444. https://doi.org/10.3390/nu8070444

[4] He FJ, MacGregor GA. "Beneficial effects of potassium on human health." Physiol Plant. 2008;133(4):725-35. https://pubmed.ncbi.nlm.nih.gov/18724413/

[5] Bailey JL, Sands JM, Franch HA. "Water, electrolytes, and acid-based metabolism." In: Ross AC, et al., eds. Modern Nutrition in Health and Disease. 11th ed. Baltimore, MD: Lippincott Williams & Wilkins; 2014:102-32.

[6] Sun H, Weaver CM. "Rising trend of hypokalemia prevalence in the US population and possible food causes." J Am Coll Nutr. 2021;40(3):273-9 (published online 2020). PMID: 32401639. https://pubmed.ncbi.nlm.nih.gov/32401639/

[7] U.S. Department of Health and Human Services, U.S. Department of Agriculture. "2015-2020 Dietary Guidelines for Americans." 2015.

[8] Paice BJ, Paterson KR, Onyanga-Omara F, et al. "Record linkage study of hypokalaemia in hospitalized patients." Postgrad Med J. 1986;62(725):187-91. PMID: 3714603. https://pubmed.ncbi.nlm.nih.gov/3714603/

[9] Veltri KT, Mason C. "Medication-induced hypokalemia." P T. 2015;40(3):185-90. PMID: 25798039. https://pubmed.ncbi.nlm.nih.gov/25798039/

[10] Grennan KN, Singh D, Chindris AM, Wilson JR. "Hypokalemia requiring hospitalization after taking semaglutide injections." Cureus. 2025;17(7):e87382. PMID: 40772190. https://pubmed.ncbi.nlm.nih.gov/40772190/

[11] Huang CL, Kuo E. "Mechanism of hypokalemia in magnesium deficiency." J Am Soc Nephrol. 2007;18(10):2649-52. PMID: 17804670. https://doi.org/10.1681/ASN.2007070792

[12] Whang R, Whang DD, Ryan MP. "Refractory potassium repletion. A consequence of magnesium deficiency." Arch Intern Med. 1992;152(1):40-5. PMID: 1728927. https://pubmed.ncbi.nlm.nih.gov/1728927/

[14] NIH Office of Dietary Supplements. "Potassium — Health Professional Fact Sheet." Updated June 2, 2022. https://ods.od.nih.gov/factsheets/Potassium-HealthProfessional/

[15] Macdonald-Clarke CJ, Martin BR, McCabe LD, et al. "Bioavailability of potassium from potatoes and potassium gluconate: a randomized dose response trial." Am J Clin Nutr. 2016;104(2):346-53. PMID: 27413123. https://pubmed.ncbi.nlm.nih.gov/27413123/

[16] Levene DL. "The absorption of potassium chloride--liquid vs. tablet." Can Med Assoc J. 1973;108(12):1480 passim. PMID: 4714871. https://pubmed.ncbi.nlm.nih.gov/4714871/

[17] Phillips R, Hanchanale VS, Myatt A, et al. "Citrate salts for preventing and treating calcium containing kidney stones in adults." Cochrane Database Syst Rev. 2015;(10):CD010057. PMID: 26439475. https://doi.org/10.1002/14651858.CD010057.pub2

[18] Soygür T, Akbay A, Küpeli S. "Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial." J Endourol. 2002;16(3):149-52. PMID: 12028622. https://pubmed.ncbi.nlm.nih.gov/12028622/

[19] Barbera M, Tsirgiotis A, Barbera M, Paola Q. "The importance of potassium citrate and potassium bicarbonate in the treatment of uric acid renal stones." Arch Ital Urol Androl. 2016;88(4):341-2. PMID: 28073209. https://pubmed.ncbi.nlm.nih.gov/28073209/

[20] Pak CY, Sakhaee K, Fuller C. "Successful management of uric acid nephrolithiasis with potassium citrate." Kidney Int. 1986;30(3):422-8. PMID: 3784284. https://pubmed.ncbi.nlm.nih.gov/3784284/

[21] Heller HJ, Reza-Albarrán AA, Breslau NA, Pak CY. "Sustained reduction in urinary calcium during long-term treatment with slow release neutral potassium phosphate in absorptive hypercalciuria." J Urol. 1998;159(5):1451-5. PMID: 9554331. https://pubmed.ncbi.nlm.nih.gov/9554331/

[22] Chan RJ, Parikh N, Ahmed S, Ruzicka M, et al. "Blood pressure control should focus on more potassium: controversies in hypertension." Hypertension. 2024;81(3):501-9 (published online 2023). PMID: 37641923. https://pubmed.ncbi.nlm.nih.gov/37641923/

[23] Neal B, Wu Y, Feng X, et al. "Effect of salt substitution on cardiovascular events and death." N Engl J Med. 2021;385(12):1067-77. PMID: 34459569. https://doi.org/10.1056/NEJMoa2105675

[24] Tucker KL, Hannan MT, Chen H, et al. "Potassium, magnesium, and fruit and vegetable intakes are associated with greater bone mineral density in elderly men and women." Am J Clin Nutr. 1999;69(4):727-36. https://pubmed.ncbi.nlm.nih.gov/10197575/

[25] Dawson-Hughes B, Harris SS, Palermo NJ, et al. "Potassium bicarbonate supplementation lowers bone turnover and calcium excretion in older men and women: a randomized dose-finding trial." J Bone Miner Res. 2015;30(11):2103-11. PMID: 25990255. https://pubmed.ncbi.nlm.nih.gov/25990255/

[26] U.S. Food and Drug Administration. Code of Federal Regulations Title 21. 21CFR201.306. Potassium salt preparations intended for oral ingestion by man. 2017.

[27] Allen AC, Boley SJ, Schultz L, Schwartz S. "Potassium-induced lesions of the small bowel. II. Pathology and pathogenesis." JAMA. 1965;193:1001-6. PMID: 14338797. https://pubmed.ncbi.nlm.nih.gov/14338797/

[28] Suh A, DeJesus E, Rosner K, et al. "Racial differences in potassium disposal." Kidney Int. 2004;66(3):1076-81. PMID: 15327401. https://pubmed.ncbi.nlm.nih.gov/15327401/

[30] Filippini T, Violi F, D'Amico R, Vinceti M. "The effect of potassium supplementation on blood pressure in hypertensive subjects: a systematic review and meta-analysis." Int J Cardiol. 2017;230:127-35. https://pubmed.ncbi.nlm.nih.gov/28024910/

[31] Binia A, Jaeger J, Hu Y, et al. "Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials." J Hypertens. 2015;33(8):1509-20. https://pubmed.ncbi.nlm.nih.gov/26039623/

[32] Cappuccio FP, MacGregor GA. "Does potassium supplementation lower blood pressure? A meta-analysis of published trials." J Hypertens. 1991;9(5):465-73. https://pubmed.ncbi.nlm.nih.gov/1649867/

[33] Whelton PK, He J, Cutler JA, et al. "Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials." JAMA. 1997;277(20):1624-32. https://pubmed.ncbi.nlm.nih.gov/9168293/

[34] Agency for Healthcare Research and Quality (Newberry SJ, Chung M, Anderson CAM, et al.). "Sodium and Potassium Intake: Effects on Chronic Disease Outcomes and Risks." Comparative Effectiveness Review No. 206. Rockville, MD; 2018. PMID: 30125063. https://pubmed.ncbi.nlm.nih.gov/30125063/ See also: National Academies of Sciences. DRIs for Sodium and Potassium. 2019.

[35] Jones DW, Ferdinand KC, Taler SJ, et al. "2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines." Hypertension. 2025;82(10):e212-e316. PMID: 40811516. https://doi.org/10.1161/HYP.0000000000000249. See also: McEvoy JW, et al. Eur Heart J. 2024.

[36] Filippini T, Naska A, Kasdagli MI, et al. "Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials." J Am Heart Assoc. 2020;9(12):e015719. PMID: 32500831. https://pubmed.ncbi.nlm.nih.gov/32500831/

[37] Dickinson HO, Nicolson DJ, Campbell F, et al. "Potassium supplementation for the management of primary hypertension in adults." Cochrane Database Syst Rev. 2006;(3):CD004641. PMID: 16856053. https://pubmed.ncbi.nlm.nih.gov/16856053/

[39] Whelton PK, et al. "2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults." Hypertension. 2018;71(6):e13-e115. https://doi.org/10.1161/HYP.0000000000000065

[40] Xu X, Zeng L, Jha V, et al. "Potassium-enriched salt substitutes: a review of recommendations in clinical management guidelines." Hypertension. 2024;81(3):400-14. PMID: 38284271. https://pubmed.ncbi.nlm.nih.gov/38284271/

[41] Aaron KJ, Sanders PW. "Role of dietary salt and potassium intake in cardiovascular health and disease." Mayo Clin Proc. 2013;88(9):987-95. https://pubmed.ncbi.nlm.nih.gov/24001491/

[42] D'Elia L, Barba G, Cappuccio FP, Strazzullo P. "Potassium intake, stroke, and cardiovascular disease: a meta-analysis of prospective studies." J Am Coll Cardiol. 2011;57(10):1210-9. https://pubmed.ncbi.nlm.nih.gov/21371638/

[43] Aburto NJ, Hanson S, Gutierrez H, et al. "Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses." BMJ. 2013;346:f1378. https://doi.org/10.1136/bmj.f1378

[44] Vinceti M, Filippini T, Crippa A, et al. "Meta-Analysis of Potassium Intake and the Risk of Stroke." J Am Heart Assoc. 2016;5(10):e004210. https://doi.org/10.1161/JAHA.116.004210

[45] U.S. Food and Drug Administration. "Food Labeling: Revision of the Nutrition and Supplement Facts Labels." Federal Register. 2016;81(103):33894-33895.

[46] Greer RC, Marklund M, Anderson CAM, et al. "Potassium-enriched salt substitutes as a means to lower blood pressure: benefits and risks." Hypertension. 2020;75(2):266-74. PMID: 31838902. https://pubmed.ncbi.nlm.nih.gov/31838902/

[47] Ding X, Zhang X, Huang L, et al. "Salt substitution and recurrent stroke and death: a randomized clinical trial." JAMA Cardiol. 2025;10(4):343-50. PMID: 39908026. https://pubmed.ncbi.nlm.nih.gov/39908026/

[48] Yuan Y, Jin A, Neal B, et al. "Salt substitution and salt-supply restriction for lowering blood pressure in elderly care facilities: a cluster-randomized trial." Nat Med. 2023;29(4):973-81. PMID: 37055566. https://pubmed.ncbi.nlm.nih.gov/37055566/

[49] Maalouf NM, Moe OW, Adams-Huet B, Sakhaee K. "Hypercalciuria associated with high dietary protein intake is not due to acid load." J Clin Endocrinol Metab. 2011;96(12):3733-40. PMID: 21976719. https://pubmed.ncbi.nlm.nih.gov/21976719/

[51] Barcelo P, Wuhl O, Servitge E, et al. "Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis." J Urol. 1993;150(6):1761-4. https://pubmed.ncbi.nlm.nih.gov/8230497/

[52] Ettinger B, Pak CY, Citron JT, et al. "Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis." J Urol. 1997;158(6):2069-73. PMID: 9366314. https://pubmed.ncbi.nlm.nih.gov/9366314/

[53] Curhan GC, Willett WC, Rimm EB, Stampfer MJ. "A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones." N Engl J Med. 1993;328(12):833-8. https://pubmed.ncbi.nlm.nih.gov/8441427/

[54] Curhan GC, Willett WC, Speizer FE, et al. "Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women." Ann Intern Med. 1997;126(7):497-504. https://pubmed.ncbi.nlm.nih.gov/9092314/

[55] Weaver CM. "Potassium and health." Adv Nutr. 2013;4(3):368S-77S. https://pubmed.ncbi.nlm.nih.gov/23674806/

[56] Hanley DA, Whiting SJ. "Does a high dietary acid content cause bone loss, and can bone loss be prevented with an alkaline diet?" J Clin Densitom. 2013;16(4):420-5. PMID: 24094472. https://pubmed.ncbi.nlm.nih.gov/24094472/

[58] Lin PH, Ginty F, Appel LJ, et al. "The DASH diet and sodium reduction improve markers of bone turnover and calcium metabolism in adults." J Nutr. 2003;133(10):3130-6. https://pubmed.ncbi.nlm.nih.gov/14519796/

[59] Moseley KF, Weaver CM, Appel L, et al. "Potassium citrate supplementation results in sustained improvement in calcium balance in older men and women." J Bone Miner Res. 2013;28(3):497-504. PMID: 22991267. https://pubmed.ncbi.nlm.nih.gov/22991267/

[60] Jehle S, Hulter HN, Krapf R. "Effect of potassium citrate on bone density, microarchitecture, and fracture risk in healthy older adults without osteoporosis: a randomized controlled trial." J Clin Endocrinol Metab. 2013;98(1):207-17. https://pubmed.ncbi.nlm.nih.gov/23162100/

[62] Macdonald HM, Black AJ, Aucott L, et al. "Effect of potassium citrate supplementation or increased fruit and vegetable intake on bone metabolism in healthy postmenopausal women: a randomized controlled trial." Am J Clin Nutr. 2008;88(2):465-74. https://pubmed.ncbi.nlm.nih.gov/18689384/

[63] Zillich AJ, Garg J, Basu S, et al. "Thiazide diuretics, potassium, and the development of diabetes: a quantitative review." Hypertension. 2006;48(2):219-24. https://pubmed.ncbi.nlm.nih.gov/16801488/

[64] Chatterjee R, Colangelo LA, Yeh HC, et al. "Potassium intake and risk of incident type 2 diabetes mellitus: the CARDIA Study." Diabetologia. 2012;55(5):1295-303. https://pubmed.ncbi.nlm.nih.gov/22322920/

[65] Colditz GA, Manson JE, Stampfer MJ, et al. "Diet and risk of clinical diabetes in women." Am J Clin Nutr. 1992;55(5):1018-23. https://pubmed.ncbi.nlm.nih.gov/1315120/

[66] Chatterjee R, Yeh HC, Shafi T, et al. "Serum and dietary potassium and risk of incident type 2 diabetes mellitus: the ARIC study." Arch Intern Med. 2010;170(19):1745-51. https://pubmed.ncbi.nlm.nih.gov/20975023/

[67] Chatterjee R, Zelnick L, Mukamal KJ, et al. "Potassium measures and their associations with glucose and diabetes risk: the Multi-Ethnic Study of Atherosclerosis (MESA)." PLoS One. 2016;11(6):e0157252. PMID: 27280455. https://pubmed.ncbi.nlm.nih.gov/27280455/

[68] Chatterjee R, Slentz C, Davenport CA, et al. "Effects of potassium supplements on glucose metabolism in African Americans with prediabetes: a pilot trial." Am J Clin Nutr. 2017;106(6):1431-8. PMID: 29092881. https://pubmed.ncbi.nlm.nih.gov/29092881/

[70] Kianifard T, et al. "An adjunct role of potassium rich vegetarian diet and a novel potassium food supplement to improve pain in chronic rheumatoid arthritis on supervised standard care: a randomized controlled study." medRxiv. 2022. https://doi.org/10.1101/2022.06.24.22276843. Published as: Kianifard T, Saluja M, Sarmukaddam S, et al. BMJ Nutr Prev Health. 2024;7(1):14-25. PMID: 38966106. https://pubmed.ncbi.nlm.nih.gov/38966106/

[71] Allen RE, Kirby KA. "Nocturnal leg cramps." Am Fam Physician. 2012;86(4):350-5. https://pubmed.ncbi.nlm.nih.gov/22963024/

[72] Mizanur Rouf Choudhury. "Use of potassium citrate in restless leg syndrome (RLS)." Pharm Pharmacol Int J. 2016;4(4). https://doi.org/10.15406/ppij.2016.04.00079

[73] Chen D, Li X, Song Q, et al. "Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China." JAMA Netw Open. 2020;3(6):e2011122. PMID: 32525548. https://pubmed.ncbi.nlm.nih.gov/32525548/

[74] Alfano G, Ferrari A, Fontana F, et al. "Hypokalemia in patients with COVID-19." Clin Exp Nephrol. 2021;25(4):401-9. PMID: 33398605. https://pubmed.ncbi.nlm.nih.gov/33398605/

[75] National Academies of Sciences. "Dietary Reference Intakes for Sodium and Potassium." Washington, DC: The National Academies Press; 2019. (Note: Previous AI for adults was 4,700 mg in 2005.)

[76] Hey H, Jørgensen F, Sørensen K, et al. "Oesophageal transit of six commonly used tablets and capsules." Br Med J (Clin Res Ed). 1982;285(6356):1717-9. PMID: 6816343. https://pubmed.ncbi.nlm.nih.gov/6816343/

[77] Narasaki Y, Okuda Y, Kalantar SS, et al. "Dietary potassium intake and mortality in a prospective hemodialysis cohort." J Ren Nutr. 2021;31(4):411-20. PMID: 33121888. https://pubmed.ncbi.nlm.nih.gov/33121888/

[78] Chocano-Bedoya PO, Manson JE, Hankinson SE, et al. "Intake of selected minerals and risk of premenstrual syndrome." Am J Epidemiol. 2013;177(10):1118-27. PMID: 23444100. https://doi.org/10.1093/aje/kws363

[79] Kusunoki M, Fujihara T, Ishida R, Yamamori Y. "Hyperkalemia caused by potassium-enriched salt in a hospitalized patient." Cureus. 2025;17(6):e86704. PMID: 40718189. https://pubmed.ncbi.nlm.nih.gov/40718189/

[80] Abe K. "A patient developed painful muscle cramps due to overeating mangos." Case Rep Neurol Med. 2012;2012:742125. PMID: 23091750. https://pubmed.ncbi.nlm.nih.gov/23091750/

[81] Raebel MA. "Hyperkalemia associated with use of ACE inhibitors and ARBs." Cardiovasc Ther. 2012;30(3):e156-66. https://pubmed.ncbi.nlm.nih.gov/21883995/

[83] Dockery S, Dupré A, Deflorio P, Murray BP. "Emergency department presentation of life-threatening symptomatic hyperkalemia from an angiotensin receptor blocker in a low-risk individual." Mil Med. 2023;188(9-10):3242-7. PMID: 36454619. https://pubmed.ncbi.nlm.nih.gov/36454619/

[84] Sarafidis PA, Georgianos PI, Lasaridis AN. "Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy." Expert Opin Drug Saf. 2010;9(2):259-73. PMID: 20095916. https://pubmed.ncbi.nlm.nih.gov/20095916/

[85] Fang L, Karakiulakis G, Roth M. "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?" Lancet Respir Med. 2020;8(4):e21. PMID: 32171062. https://pubmed.ncbi.nlm.nih.gov/32171062/

[86] Diaz JH. "ACE inhibitors, ARBs, and COVID-19." J Travel Med. 2020;27(3):taaa041. https://doi.org/10.1093/jtm/taaa041

[87] Danser AHJ, et al. "Renin-angiotensin system blockers and COVID-19." Hypertension. 2020;75(6):1382-5. https://doi.org/10.1161/HYPERTENSIONAHA.120.15082

[89] U.S. Department of Agriculture, Agricultural Research Service. "FoodData Central." https://fdc.nal.usda.gov/

[90] O'Neil CE, Keast DR, Fulgoni VL, Nicklas TA. "Food sources of energy and nutrients among adults in the US: NHANES 2003-2006." Nutrients. 2012;4(12):2097-120. https://pubmed.ncbi.nlm.nih.gov/23363999/

[91] Keast DR, Fulgoni VL 3rd, Nicklas TA, O'Neil CE. "Food sources of energy and nutrients among children in the United States: NHANES 2003-2006." Nutrients. 2013;5(1):283-301. https://pubmed.ncbi.nlm.nih.gov/23340318/

[92] Stanfield B. Salt-substitutes can slash your 5-year death risk by 12%. drstanfield.com. 2 April 2025. https://drstanfield.com/blogs/articles/salt-substitutes-can-slash-your-death-risk-by-12

[93] Makunts T, Cohen IV, Awdishu L, Abagyan R. "Analysis of postmarketing safety data for proton-pump inhibitors reveals increased propensity for renal injury, electrolyte abnormalities, and nephrolithiasis." Sci Rep. 2019;9(1):2282. PMID: 30783195. https://pubmed.ncbi.nlm.nih.gov/30783195/

[94] McCord GS, Clouse RE. "Pill-induced esophageal strictures: clinical features and risk factors for development." Am J Med. 1990;88(5):512-8. DOI: 10.1016/0002-9343(90)90431-c. PMID: 2186626. https://pubmed.ncbi.nlm.nih.gov/2186626/

[95] Antoniou T, Gomes T, Juurlink DN, Loutfy MR, Glazier RH, Mamdani MM. "Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study." Arch Intern Med. 2010;170(12):1045-9. DOI: 10.1001/archinternmed.2010.142. PMID: 20585070. https://pubmed.ncbi.nlm.nih.gov/20585070/

Back to blog